Concepts (123)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Simian virus 40 | 8 | 2009 | 196 | 0.640 |
Why?
|
| Pneumonia, Viral | 4 | 2021 | 399 | 0.460 |
Why?
|
| Intensive Care Units | 4 | 2021 | 538 | 0.420 |
Why?
|
| Polyomavirus Infections | 5 | 2009 | 91 | 0.410 |
Why?
|
| Tumor Virus Infections | 6 | 2004 | 141 | 0.410 |
Why?
|
| Coronavirus Infections | 3 | 2020 | 388 | 0.340 |
Why?
|
| Heart Diseases | 1 | 2012 | 526 | 0.270 |
Why?
|
| Critical Care | 3 | 2022 | 681 | 0.260 |
Why?
|
| Extracorporeal Membrane Oxygenation | 1 | 2012 | 639 | 0.240 |
Why?
|
| DNA, Viral | 6 | 2009 | 497 | 0.240 |
Why?
|
| Pandemics | 6 | 2022 | 1191 | 0.230 |
Why?
|
| Medical Laboratory Personnel | 1 | 2004 | 10 | 0.220 |
Why?
|
| Laboratories, Hospital | 1 | 2004 | 24 | 0.220 |
Why?
|
| Antigens, Polyomavirus Transforming | 2 | 2004 | 88 | 0.220 |
Why?
|
| Practice Guidelines as Topic | 2 | 2021 | 1333 | 0.210 |
Why?
|
| Meningioma | 1 | 2004 | 140 | 0.190 |
Why?
|
| Quality of Life | 1 | 2012 | 2127 | 0.190 |
Why?
|
| Nurse Practitioners | 1 | 2022 | 50 | 0.180 |
Why?
|
| Transportation of Patients | 1 | 2021 | 54 | 0.170 |
Why?
|
| Physician Assistants | 1 | 2022 | 71 | 0.170 |
Why?
|
| Vaping | 1 | 2020 | 30 | 0.170 |
Why?
|
| Betacoronavirus | 2 | 2020 | 309 | 0.160 |
Why?
|
| Acute Lung Injury | 1 | 2020 | 68 | 0.160 |
Why?
|
| Cough | 1 | 2020 | 96 | 0.160 |
Why?
|
| Mesothelioma | 2 | 2003 | 94 | 0.160 |
Why?
|
| Dexamethasone | 1 | 2021 | 285 | 0.160 |
Why?
|
| Pleural Neoplasms | 1 | 2000 | 82 | 0.150 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2021 | 339 | 0.150 |
Why?
|
| Leukemia | 1 | 2021 | 378 | 0.140 |
Why?
|
| Fever | 1 | 2020 | 309 | 0.140 |
Why?
|
| Enterocolitis, Necrotizing | 1 | 2021 | 248 | 0.140 |
Why?
|
| Disease Management | 1 | 2021 | 558 | 0.130 |
Why?
|
| Communicable Diseases, Emerging | 1 | 2017 | 67 | 0.130 |
Why?
|
| Sepsis | 1 | 2020 | 525 | 0.120 |
Why?
|
| Brain Neoplasms | 2 | 2004 | 1400 | 0.120 |
Why?
|
| Polymerase Chain Reaction | 6 | 2009 | 1632 | 0.110 |
Why?
|
| Critical Illness | 3 | 2022 | 621 | 0.100 |
Why?
|
| Delivery of Health Care | 1 | 2017 | 676 | 0.090 |
Why?
|
| Humans | 21 | 2022 | 133589 | 0.080 |
Why?
|
| Lung Neoplasms | 1 | 2000 | 1796 | 0.080 |
Why?
|
| Texas | 3 | 2021 | 3678 | 0.080 |
Why?
|
| Pediatrics | 1 | 2017 | 1209 | 0.070 |
Why?
|
| Child | 8 | 2022 | 25711 | 0.070 |
Why?
|
| Infectious Disease Transmission, Vertical | 1 | 2009 | 253 | 0.070 |
Why?
|
| Infant | 5 | 2021 | 13123 | 0.060 |
Why?
|
| Male | 9 | 2021 | 65783 | 0.060 |
Why?
|
| Hospitals, Pediatric | 2 | 2021 | 791 | 0.060 |
Why?
|
| Polyomavirus | 2 | 2002 | 32 | 0.060 |
Why?
|
| Papillomavirus Infections | 2 | 1999 | 398 | 0.060 |
Why?
|
| Poliovirus Vaccines | 1 | 2003 | 14 | 0.050 |
Why?
|
| Drug Contamination | 1 | 2003 | 38 | 0.050 |
Why?
|
| Gadolinium | 1 | 2004 | 118 | 0.050 |
Why?
|
| Adolescent | 5 | 2021 | 20512 | 0.050 |
Why?
|
| Patient Acuity | 1 | 2022 | 68 | 0.050 |
Why?
|
| Sequence Homology, Nucleic Acid | 2 | 2000 | 295 | 0.050 |
Why?
|
| Young Adult | 3 | 2021 | 9897 | 0.050 |
Why?
|
| Female | 7 | 2021 | 71528 | 0.050 |
Why?
|
| Child, Preschool | 4 | 2021 | 14762 | 0.050 |
Why?
|
| Herpesvirus 3, Human | 1 | 2021 | 30 | 0.050 |
Why?
|
| Ventilation | 1 | 2021 | 5 | 0.050 |
Why?
|
| Kidney Transplantation | 3 | 2002 | 681 | 0.050 |
Why?
|
| Hospitalization | 2 | 2020 | 1878 | 0.050 |
Why?
|
| Hydroxychloroquine | 1 | 2021 | 20 | 0.040 |
Why?
|
| Adenosine Monophosphate | 1 | 2021 | 42 | 0.040 |
Why?
|
| Immunization, Passive | 1 | 2021 | 128 | 0.040 |
Why?
|
| Patient Positioning | 1 | 2021 | 56 | 0.040 |
Why?
|
| Polymorphism, Genetic | 1 | 2004 | 896 | 0.040 |
Why?
|
| Alanine | 1 | 2021 | 189 | 0.040 |
Why?
|
| Diagnostic Techniques and Procedures | 1 | 2020 | 32 | 0.040 |
Why?
|
| Sequence Analysis, DNA | 2 | 2004 | 1834 | 0.040 |
Why?
|
| Retrospective Studies | 4 | 2022 | 17437 | 0.040 |
Why?
|
| Immunization | 1 | 2021 | 315 | 0.040 |
Why?
|
| Shock | 1 | 2020 | 97 | 0.040 |
Why?
|
| Infection Control | 1 | 2020 | 150 | 0.040 |
Why?
|
| Sequence Alignment | 1 | 2000 | 633 | 0.040 |
Why?
|
| Monkey Diseases | 1 | 1998 | 18 | 0.040 |
Why?
|
| Soft Tissue Neoplasms | 1 | 2000 | 127 | 0.040 |
Why?
|
| Base Sequence | 2 | 2000 | 3169 | 0.040 |
Why?
|
| Neoplasms | 2 | 2003 | 3012 | 0.040 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2020 | 542 | 0.040 |
Why?
|
| Colon | 1 | 2021 | 381 | 0.040 |
Why?
|
| Lymph Nodes | 1 | 2000 | 402 | 0.040 |
Why?
|
| Molecular Sequence Data | 2 | 2000 | 3970 | 0.030 |
Why?
|
| Infant, Newborn | 2 | 2021 | 8572 | 0.030 |
Why?
|
| Survivors | 1 | 2020 | 361 | 0.030 |
Why?
|
| Capsid Proteins | 1 | 1998 | 194 | 0.030 |
Why?
|
| Respiration, Artificial | 1 | 2020 | 489 | 0.030 |
Why?
|
| Feces | 1 | 2021 | 785 | 0.030 |
Why?
|
| Evidence-Based Medicine | 1 | 2021 | 667 | 0.030 |
Why?
|
| Hemodynamics | 1 | 2021 | 872 | 0.030 |
Why?
|
| Macaca mulatta | 1 | 1998 | 513 | 0.030 |
Why?
|
| Cell Line, Tumor | 1 | 2004 | 3730 | 0.030 |
Why?
|
| Risk Factors | 2 | 2017 | 11054 | 0.030 |
Why?
|
| Treatment Outcome | 2 | 2020 | 13003 | 0.030 |
Why?
|
| Anticoagulants | 1 | 2021 | 598 | 0.030 |
Why?
|
| Immunocompromised Host | 1 | 1998 | 304 | 0.030 |
Why?
|
| Diagnosis, Differential | 1 | 2020 | 1967 | 0.030 |
Why?
|
| Cohort Studies | 1 | 2022 | 5180 | 0.030 |
Why?
|
| Antibodies, Viral | 3 | 2009 | 1204 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2004 | 3840 | 0.020 |
Why?
|
| Mesocricetus | 1 | 2009 | 74 | 0.020 |
Why?
|
| Cricetinae | 1 | 2009 | 398 | 0.020 |
Why?
|
| Spleen | 1 | 2009 | 291 | 0.020 |
Why?
|
| United States | 1 | 2022 | 11654 | 0.020 |
Why?
|
| Placenta | 1 | 2009 | 535 | 0.010 |
Why?
|
| Denmark | 1 | 2003 | 29 | 0.010 |
Why?
|
| Blotting, Southern | 1 | 2003 | 222 | 0.010 |
Why?
|
| Adult | 1 | 2004 | 31933 | 0.010 |
Why?
|
| Brain | 2 | 2009 | 3211 | 0.010 |
Why?
|
| Lymphoma, Non-Hodgkin | 1 | 2003 | 168 | 0.010 |
Why?
|
| Middle Aged | 1 | 2000 | 29349 | 0.010 |
Why?
|
| Culture Techniques | 1 | 1998 | 82 | 0.010 |
Why?
|
| Bone Neoplasms | 1 | 2003 | 462 | 0.010 |
Why?
|
| Wilms Tumor | 1 | 1999 | 119 | 0.010 |
Why?
|
| Capsid | 1 | 1998 | 147 | 0.010 |
Why?
|
| Genetic Heterogeneity | 1 | 1998 | 142 | 0.010 |
Why?
|
| Leukocytes | 1 | 1998 | 224 | 0.010 |
Why?
|
| Pregnancy | 1 | 2009 | 7506 | 0.010 |
Why?
|
| Incidence | 1 | 2003 | 3386 | 0.010 |
Why?
|
| Kidney Neoplasms | 1 | 1999 | 460 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 1998 | 2785 | 0.010 |
Why?
|
| Animals | 2 | 2009 | 36308 | 0.010 |
Why?
|
| Genetic Variation | 1 | 1998 | 1611 | 0.010 |
Why?
|